Want to join the conversation?
Biopharmaceutical giant $BMY said it agreed to buy private biotechnology company Cardioxyl Pharmaceuticals in a deal where $BMY will pay $300MM upfront and about $1.775Bil upon achieving certain milestones. The deal is expected to be dilutive to $BMY's 2015 GAAP EPS by about $0.12, with minimal dilution to non-GAAP EPS in both 2015 & 2016.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.